Optimisation modelling of cancer growth

Tiffany A. Jones; Lou Caccetta; Volker Rehbock

doi:10.3934/dcdsb.2017006

Article Contents

2017, Volume 22, Issue 1: 115-123. Doi: 10.3934/dcdsb.2017006

This issue Previous Article Property and numerical simulation of the Ait-Sahalia-Rho model with nonlinear growth conditions Next Article A review of dynamic Stackelberg game models

Optimisation modelling of cancer growth

Western Australian Centre of Excellence in Industrial Optimisation, Curtin University, Perth, 6102, Australia and Department of Mathematics and Statistics, Curtin University, Perth, 6102, Australia

* Corresponding author: Tiffany A. Jones
* Corresponding author: Tiffany A. Jones

Received: January 2016

Revised: June 2016

Published: November 2017

Abstract Full Text(HTML) Figure(0) / Table(3) Related Papers Cited by

Abstract

Several computational models have been developed in the literature to describe the dynamics of the cell-cycle for the mammalian cell, in particular for cancer cells, using both traditional and new techniques and yielding some positive results. In this paper, we discuss how to optimise model parameters for these types of models and how this can serve to enhance numerical results. We pose the model parameter selection problem as an optimal parameter selection problem on both a normal cell and cancer cell cycle of growth. Various possible objectives are discussed and we illustrate the process with some numerical results.

Keywords:

Mathematics Subject Classification: Primary:90C90;Secondary:92-08.

Citation:

Full Text(HTML)

Table 1. Results from MISER3.3 for Multiple Characteristic Time points

$\mathbf{\zeta}$	Initial Value	MISER3.3	Rounded	Tyson
$\zeta_{1}$	0.04	0.048528	0.05	0.04
$\zeta_{2}$	0.04	0.0420341	0.04	0.04
$\zeta_{3}$	1.5	1.00497	1.0	1.0
$\zeta_{4}$	1.5	1.09633	1.1	1.0
$\zeta_{5}$	12.0	9.74194	10.0	10.0
$\zeta_{6}$	35.0	35.7286	36.0	35.0
$\zeta_{7}$	0.005	0.00490765	0.005	0.005
$\zeta_{8}$	0.2	0.199762	0.2	0.2
$\zeta_{9}$	0.1	0.099762	0.1	0.1
$\zeta_{10}$	1.2	1.00158	1.0	1.0
$\zeta_{11}$	0.6	0.502537	0.5	0.5
$\zeta_{12}$	0.2	0.101318	0.1	0.1
$\zeta_{13}$	0.01	0.020161	0.02	0.02
$\zeta_{14}$	0.01	0.009979	0.01	0.01

| Show Table

DownLoad: CSV

Table 2. Table of $\tau_{i}$ values for characteristic time points

$ \begin{gathered} \overline {\underline {{\tau _i}\;\;{\text{Times}}} } \hfill \\ {\tau _1}\;\;0 \hfill \\ {\tau _2}\;\;142 \hfill \\ {\tau _3}\;\;284 \hfill \\ {\tau _4}\;\;426 \hfill \\ {\tau _5}\;\;568 \hfill \\ {\tau _6}\;\;710 \hfill \\ {\tau _7}\;\;852 \hfill \\ {\tau _8}\;\;994 \hfill \\ {\tau _9}\;\;1136 \hfill \\ {\tau _{10}}\;\;1278 \hfill \\ \underline {{\tau _{11}}\;\;1420} \hfill \\ \end{gathered} $

| Show Table

DownLoad: CSV

Table 3. Table of simulated parameter values

$\mathbf{\zeta}$	MISER3.3	Rounded	Alarcón
$\zeta_{1}$	0.00864931	0.009	0.04
$\zeta_{2}$	0.990733	1.0	1.0
$\zeta_{3}$	0.330044	0.33	0.25
$\zeta_{4}$	0.0807658	0.08	0.04
$\zeta_{5}$	10.0014	10.0	10.0
$\zeta_{6}$	3.49825	3.5	3.5
$\zeta_{7}$	0.0966571	0.1	0.01
$\zeta_{8}$	0.07	0.07	0.007
$\zeta_{9}$	0.0195864	0.02	0.01
$\zeta_{10}$	0.00721735	0.007	0.01
$\zeta_{11}$	0.000292239	0.0003	0.01
$\zeta_{12}$	0.00494411	0.005	0.1

| Show Table

DownLoad: CSV

Related Papers

Cited by

References

	T. Alarcón , H. M. Byrne and P. K. Maini , A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells, JTB, 229 (2004) , 397-411.
	S. Dormann and A. Deutsch , Modeling of self-organized avascular tumor growth with a hybrid cellular automaton, In Silico Biology, 2 (2002) , 393-406.
	L. S. Jennings, M. E. Fisher, K. L. Teo and C. J. Goh, MISER3 Optimal Control Software: Theory and User Manual. Version 3 The Department of Mathematics, The University of Western Australia, Nedlands, Western Australia, 2004.
	T. A. Jones, Mathematical Modelling Of Cancer Growth Ph. D thesis, Curtin University in Bentley, Western Australia, 2014.
	R. C. Loxton , K. L. Teo and V. Rehbock , Optimal control problems with multiple characteristic time points in the objective and constraints, Automatica, 44 (2008) , 2923-2929. doi: 10.1016/j.automatica.2008.04.011.
	R. B. Martin , Optimal control drug scheduling of cancer chemotherapy, Automatica, 28 (1992) , 1113-1123. doi: 10.1016/0005-1098(92)90054-J.
	R. Martin and K. L. Teo, Optimal Control of Drug Administration in Cancer Chemotherapy World Scientific Publishing Company Pte. Ltd, Singapore, 1994. doi: 10.1142/2048.
	K. L. Teo, C. J. Goh and K. H. Wong, A Unified Computational Approach to Optimal Control Problems Longman Scientific & Technical, Essex, England, 1991.
	J. J. Tyson and B. Novak , Regulation of the eukaryotic cell cycle: Molecular antagonism, hysteresis, and irreversible transitions, JTB, 210 (2001) , 249-263. doi: 10.1006/jtbi.2001.2293.
	World Health Organization, Media Centre -Cancer Electronically on World Wide Web, 2012. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/.
	R. A. Weinberg, The Biology of Cancer Garland Science, New York, 2007.